opc 21268 has been researched along with obe001 in 1 studies
| Studies (opc 21268) | Trials (opc 21268) | Recent Studies (post-2010) (opc 21268) | Studies (obe001) | Trials (obe001) | Recent Studies (post-2010) (obe001) |
|---|---|---|---|---|---|
| 133 | 3 | 6 | 8 | 2 | 7 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Borthwick, AD | 1 |
1 other study(ies) available for opc 21268 and obe001
| Article | Year |
|---|---|
Oral oxytocin antagonists.
Topics: Administration, Oral; Animals; Biological Availability; Camphor; Humans; Indoles; Oxytocin; Piperazines; Piperidines; Protein Conformation; Pyrrolidines; Receptors, Oxytocin; Sulfonamides; Triazoles | 2010 |